FDA warns obesity doctor over implants
WASHINGTON - A Los Angeles-area doctor who lent his name to a type of stomach-shrinking surgery failed to obtain the full informed consent of 175 patients implanted with an experimental medical device, according to a federal warning letter released Tuesday.
FDA proposes report cards on new drugs
Military creates mental health hotline
Glaxo distorted Paxil drug test data: BBC
100 Percent Juices Found As Beneficial To Health As Fruits And Vegetables
Louisiana Plan To Cover Uninsured Could Cost Less Than Previously Estimated
MedInsight(SM) Announces Clinical Trial Results Of Low-dose Naltrexone; Potential Breakthrough For Crohn's Disease Patients
World's First Users Meeting On Endoluminal Surgery Unites Leading Digestive Surgeons And Gastroenterologists Throughout Europe
Top Hospitals Have 28 Percent Lower Mortality Rate, Annual Study Finds
No comments:
Post a Comment